{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:37:18Z","timestamp":1792222638987,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of this study was to evaluate the regression rate of CIN2 p16 positive lesions in women over 25\u00a0years of age and identify possible predictors of regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 128 CIN2 p16 positive patients over 25\u00a0years old were considered. The women met the following inclusion criteria: HPV genotype 16, 18, 31, 33, 45 positive, HPV E6 \/ E7 mRNA test positive, without immune system pathologies, not pregnant and had completed at least two years of follow-up. At each follow-up examination patients were examined by colposcopy, HPV test, E6\/E7mRNA, targeted biopsy and p16 protein detection. The final state after the two years of follow-up was classified as progression if the histology showed a CIN3, persistence if the lesion was a CIN2, regression if negative or LSIL. The predicted regression factors evaluated were: HPV E6\/E7mRNA, protein p16.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, we had 35.1% (45 cases) of progression to CIN3, 41.4% (53 cases) of persistence and 23.4% (30 cases) of regression. The regression rate was higher in women with negative mRNA 92.8% (26\/28), OR 312 (34.12\u20131798.76) <jats:italic>p<\/jats:italic>\u2009=\u20090.0001, while women with p16 negative had a regression of 22.6% (7\/31), OR 0.94 (95% CI 0.36\u20132.46), <jats:italic>p<\/jats:italic> was not significant. We found no significant difference in regression between p16 positive (23.7%) and p16 negative (22.6%) CIN2 p16 lesions. p16 had a VPN of 22.6 (CI 95% 0.159\u20130.310), indicating that a p16 negative lesion does not exclude a CIN2\u2009+\u2009.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We had a regression rate of 23.4%, which was low if we consider that in the literature the regression rates vary from 55 to 63%. The discrepancy in the results may indeed be explained by the fact that all lesions in our study were hr-HPV positive and belonged to \u201colder women\u201d reflecting a more \"high-risk\" population. As regression factors we studied p16 and HPV E6\/E7 mRNA. The results of our study show that HPV mRNA, if negative, appears to be able to identify CIN2 lesions with a higher probability of regression and underlines how a p16 negative is not an indicator of regression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-022-01822-1","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T15:02:59Z","timestamp":1653663779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Possible role of negative human papillomavirus E6\/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-1538","authenticated-orcid":false,"given":"Maria Teresa","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazario","family":"Cassaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Giovanni","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Guaita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Boemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"issue":"3","key":"1822_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/0002-9378(69)90268-3","volume":"105","author":"RM Richart","year":"1969","unstructured":"Richart RM, Barron BA. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol. 1969;105(3):386\u201393.","journal-title":"Am J Obstet Gynecol"},{"key":"1822_CR2","first-page":"55","volume":"1288","author":"H Zur Hausen","year":"1996","unstructured":"Zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochim Biophysics Acta. 1996;1288:55\u201378.","journal-title":"Biochim Biophysics Acta"},{"key":"1822_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12\u20139.","journal-title":"J Pathol"},{"issue":"2","key":"1822_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","volume":"12","author":"AG \u00d6St\u00f6r","year":"1993","unstructured":"\u00d6St\u00f6r AG. Natural history of cervical intraepithelial Neoplasia: a critical review. Int J Gynecol Pathol. 1993;12(2):186\u201392.","journal-title":"Int J Gynecol Pathol"},{"key":"1822_CR5","first-page":"6627531","volume":"2021","author":"MT Bruno","year":"2021","unstructured":"Bruno MT, Cassaro N, Bica F, Boemi S. Progression of CIN1\/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence. Infect Dis Obst Gynecol. 2021;2021:6627531.","journal-title":"Infect Dis Obst Gynecol"},{"issue":"3","key":"1822_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","volume":"16","author":"TM Darragh","year":"2012","unstructured":"Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, McCalmont T, et al. The lower anogenital squamous terminology standardization project for hpv-associated lesions: Background and consensus recommendations from the college of american pathologists and the american society for colposcopy and cervical pathology. J Low Genit Tract Dis. 2012;16(3):205\u201342.","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"1822_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00404-020-05853-3","volume":"303","author":"JL Brun","year":"2021","unstructured":"Brun JL, Letoffet D, Marty M, Griffier R, Ah-Kit X, Garrigue I. Factors predicting the spontaneous regression of cervical high-grade squamous intraepithelial lesions (HSIL\/CIN2). Arch Gynecol Obstet. 2021;303(4):1065\u201373.","journal-title":"Arch Gynecol Obstet"},{"issue":"9446","key":"1822_CR8","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","volume":"364","author":"AB Moscicki","year":"2004","unstructured":"Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet. 2004;364(9446):1678\u201383.","journal-title":"Lancet"},{"issue":"6","key":"1822_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1159\/000497286","volume":"84","author":"J Zhang","year":"2019","unstructured":"Zhang J, Lu CX. Spontaneous regression of cervical intraepithelial neoplasia 2: a meta-analysis. Gynecol Obstet Invest. 2019;84(6):562\u20137.","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"1822_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","volume":"113","author":"PE Castle","year":"2009","unstructured":"Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009;113(1):18\u201325.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"1822_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1017\/S0950268818000250","volume":"146","author":"MT Bruno","year":"2018","unstructured":"Bruno MT, Ferrara M, Fava V, Barrasso G, Panella MM. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6\/E7 mRNA positive: A 3-year follow-up. Epidemiol Infect. 2018;146(5):612\u20138.","journal-title":"Epidemiol Infect"},{"key":"1822_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/ijc.20839","volume":"114","author":"T Molden","year":"2005","unstructured":"Molden T, Nygard JF, Kraus I, Karlsen F, Nygard M, Skare GB, et al. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL Pap smear. Int J Cancer. 2005;114:973\u20136.","journal-title":"Int J Cancer"},{"issue":"5","key":"1822_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"M McCredie","year":"2008","unstructured":"McCredie M, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425\u201334.","journal-title":"Lancet Oncol"},{"key":"1822_CR14","first-page":"k49","volume":"360","author":"K Tainio","year":"2018","unstructured":"Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, Cardenas J, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;360:k49.","journal-title":"BMJ"},{"issue":"6","key":"1822_CR15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","volume":"116","author":"AB Moscicki","year":"2010","unstructured":"Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, et al. Rate of and risks for regression of CIN-2 in adolescents and young women. Obstet Gynecol. 2010;116(6):1373\u201380.","journal-title":"Obstet Gynecol"},{"key":"1822_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jnci\/djq001","volume":"102","author":"AC Rodriguez","year":"2010","unstructured":"Rodriguez AC, Schiffman M, Herrero R, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection. J Natl Cancer Inst. 2010;102:315\u201324.","journal-title":"J Natl Cancer Inst"},{"key":"1822_CR17","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1086\/428779","volume":"191","author":"PE Castle","year":"2005","unstructured":"Castle PE, Schiffman M, Herrero R, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste. Costa Rica J Infect Dis. 2005;191:1808\u201316.","journal-title":"Costa Rica J Infect Dis"},{"key":"1822_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejogrb.2010.12.002","volume":"155","author":"MG Discacciati","year":"2011","unstructured":"Discacciati MG, De Souza CAS, D\u2019Otavianno MG, et al. Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 months. Eur J Obstet Gynecol Reprod Biol. 2011;155:204\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"1822_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijgo.2015.12.005","volume":"134","author":"S Miyamoto","year":"2016","unstructured":"Miyamoto S, Morioka M, Hirota Y, Kushima M, Sekizawa A. The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2. Int J Gynaecol Obstet. 2016;134(1):45\u20138.","journal-title":"Int J Gynaecol Obstet"},{"key":"1822_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","volume":"11","author":"G Ronco","year":"2010","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncology. 2010;11:249\u201357.","journal-title":"Lancet Oncology"},{"issue":"1","key":"1822_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12985-018-0957-z","volume":"15","author":"MT Bruno","year":"2018","unstructured":"Bruno MT, Ferrara M, Fava V, Rapisarda A, Coco A. HPV genotype determination and E6\/E7 mRNA detection for management of HPV positive women. Virol J. 2018;15(1):52.","journal-title":"Virol J"},{"issue":"6","key":"1822_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, De Sanjose S, et al. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518\u201327.","journal-title":"N Engl J Med"},{"key":"1822_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/1055-9965.EPI-08-0306","volume":"17","author":"K Cuschieri","year":"2008","unstructured":"Cuschieri K, Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomark Prev. 2008;17:10.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1822_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1309\/AJCPXSVCDZ3D5MZM","volume":"133","author":"C Bergeron","year":"2010","unstructured":"Bergeron C, Ordi J, Schmidt D, Trunk MJ, Keller T, Ridder R. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol. 2010;133:395\u2013406.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"1822_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4132\/KoreanJPathol.2012.46.3.253","volume":"46","author":"S Lee","year":"2012","unstructured":"Lee S, Kim H, Kim H, Kim C, Kim I. The utility of p16INK4a and Ki-67 as a conjunctive tool in uterine cervical lesions. Korean J Pathol. 2012;46(3):253\u201360.","journal-title":"Korean J Pathol"},{"key":"1822_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/01.pgp.0000139639.79105.40","volume":"23","author":"M Branca","year":"2004","unstructured":"Branca M, Ciotti M, Santini D, et al. p16INK4A expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol. 2004;23:354\u201365.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"1822_CR27","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.humpath.2013.10.035","volume":"45","author":"J Genoves","year":"2014","unstructured":"Genoves J, Alameda F, Mancebo G, et al. Human papillomavirus detection and p16INK4a expression in cervical lesions: a comparative study. Hum Pathol. 2014;45(4):826\u201333.","journal-title":"Hum Pathol"},{"issue":"3","key":"1822_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ctrv.2008.10.005","volume":"35","author":"I Tsoumpou","year":"2009","unstructured":"Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16 (INK4a) immunostaining in cytological and histological specimens of the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev. 2009;35(3):210\u201320.","journal-title":"Cancer Treat Rev"},{"key":"1822_CR29","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1525-1438.2007.00899.x","volume":"17","author":"AC Guedes","year":"2007","unstructured":"Guedes AC, Brenna SM, Coelho SA, Martinez EZ, Syrj\u00e4nen KJ, Zeferino LC. p16(INK4a) expression does not predict the outcome of cervical intraepithelial neoplasia grade 2. Int J Gynecol Cancer. 2007;17:1099\u2013103.","journal-title":"Int J Gynecol Cancer"},{"key":"1822_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/modpathol.2016.168","volume":"30","author":"E Miralpeix","year":"2017","unstructured":"Miralpeix E, Genov\u00e9s J, Maria Sol\u00e9-Sede\u00f1o J, Mancebo G, Lloveras B, Bellosillo B, et al. Usefulness of p16(INK4a) staining for managing histological high-grade squamous intraepithelial cervical lesions. Mod Pathol. 2017;30:304\u201310.","journal-title":"Mod Pathol"},{"key":"1822_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/modpathol.2015.126","volume":"29","author":"A Sagasta","year":"2016","unstructured":"Sagasta A, Castillo P, Saco A, Torn\u00e8 A, et al. P16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix. Mod Pathol. 2016;29:51\u20139.","journal-title":"Mod Pathol"},{"issue":"4","key":"1822_CR32","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.humpath.2013.10.035","volume":"45","author":"J Genov\u00e9s","year":"2014","unstructured":"Genov\u00e9s J, Alameda F, Mancebo G, Sol\u00e9 JM, Bellosillo B, LLoveras B, et al. Human papillomavirus detection and p16 expression in cervical lesions: a comparative study INK4a. Human Pathol. 2014;45(4):826\u201333.","journal-title":"Human Pathol"},{"key":"1822_CR33","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1097\/PAS.0000000000000494","volume":"39","author":"KP Maniar","year":"2015","unstructured":"Maniar KP, Sanchez B, Paintal A, Gursel DB, Nayar R. Role of the biomarker p16 in downgrading -IN 2 diagnoses and predicting higher-grade lesions. Am J Surg Pathol. 2015;39:1708\u201318.","journal-title":"Am J Surg Pathol"},{"key":"1822_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3802\/jgo.2013.24.3.215","volume":"24","author":"S Nishio","year":"2013","unstructured":"Nishio S, Fujii T, Nishio H, et al. p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping. J Gynecol Oncol. 2013;24:215\u201321.","journal-title":"J Gynecol Oncol"},{"key":"1822_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/PGP.0b013e31826916c7","volume":"32","author":"TM Darragh","year":"2013","unstructured":"Darragh TM, Colgan TJ, Thomas CJ, et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol. 2013;32:76\u2013115.","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"1822_CR36","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1128\/JCM.02570-10","volume":"49","author":"M Benevolo","year":"2011","unstructured":"Benevolo M, Vocaturo A, Caraceni D, French D, Rosini S, Zappacosta R, et al. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6\/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test. J Clin Microbiol. 2011;49(7):2643\u201350.","journal-title":"J Clin Microbiol."},{"issue":"11","key":"1822_CR37","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1002\/ijc.32695","volume":"146","author":"M Zorzi","year":"2020","unstructured":"Zorzi M, Del Mistro A, Rossi PG, Laurino L, Battagello J, Lorio M, et al. Risk of CIN2 or more severe lesions after negative HPV-mRNA E6\/E7 overexpression assay and after negative HPV-DNA test: concurrent cohorts with a 5-year follow-up. Int J Cancer. 2020;146(11):3114\u201323.","journal-title":"Int J Cancer"},{"issue":"3","key":"1822_CR38","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.ygyno.2005.02.026","volume":"97","author":"AK Lie","year":"2005","unstructured":"Lie AK, Risberg B, Borge B, Sandstad B, Delabie J, Rimala R, Onsrud M, Thoresen S. DNA-versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol. 2005;97(3):908\u201315.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1822_CR39","first-page":"105","volume":"113","author":"PG Rossi","year":"2021","unstructured":"Rossi PG, Carozzi F, Ronco G, Allia E, Bisanzi S. Anna gillio-tos p16\/ki67 and E6\/E7 mRNA accuracy and prognostic value in triaging HPV DNA-positive women. JNCI J Natl Cancer Inst. 2021;113(3):105.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1822_CR40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/PAS.0000000000000800","volume":"41","author":"AM Mills","year":"2017","unstructured":"Mills AM, Dirks DC, Poulter MD, Mills SE, Stoler MH. HR-HPV E6\/E7 mRNA in situ hybridization: validation against PCR, DNA in situ hybridization, and p16 immunohistochemistry in 102 samples of cervical, vulvar, anal, and head and neck Neoplasia. Am J Surg Pathol. 2017;41:607\u201315.","journal-title":"Am J Surg Pathol"},{"key":"1822_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcv.2014.01.017","volume":"60","author":"A Frega","year":"2014","unstructured":"Frega A, Sesti F, Lombardi D, Votano S, Sopracordevole F, Catalano A, et al. Assessment of HPV-mRNA test to predict recurrent disease in patients previously treated for CIN 2\/3. J Clin Virol. 2014;60:39\u201343.","journal-title":"J Clin Virol."},{"key":"1822_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1024","volume":"196","author":"M Esteller","year":"2002","unstructured":"Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 2002;196:1\u20137.","journal-title":"J Pathol"},{"issue":"2","key":"1822_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/IGC.0b013e31827da1f6","volume":"23","author":"N Oka","year":"2013","unstructured":"Oka N, Kajita M, Nishimura R, et al. L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia. Int J Gynecol Cancer. 2013;23(2):235\u201343.","journal-title":"Int J Gynecol Cancer"},{"issue":"5\u20136","key":"1822_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.11138\/giog\/2016.38.5.376","volume":"38","author":"MT Bruno","year":"2016","unstructured":"Bruno MT, Ferrara M, Fava V, Barrasso G, Cutello S, Sapia F, Panella MM. Prevalence genotypes and distribution of human papillomavirus infection in women with abnormal cervical cytology in Catania, Italy. Giornale Italiano di Ostetricia e Ginecologia. 2016;38(5\u20136):376\u201380.","journal-title":"Giornale Italiano di Ostetricia e Ginecologia"},{"key":"1822_CR45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1186\/s12879-020-05530-5","volume":"20","author":"MT Bruno","year":"2020","unstructured":"Bruno MT, Scalia G, Cassaro N, Costanzo M, Boemi S. Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection. BMC Infect Dis. 2020;20:801.","journal-title":"BMC Infect Dis"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01822-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-022-01822-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01822-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T16:03:26Z","timestamp":1653667406000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-022-01822-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1186\/s12985-022-01822-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"assertion":[{"value":"10 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was notified, according to the current legislation on observational studies provided by AIFA, to the Catania1 Ethics Committee of the Catania Polyclinic, which did not request additions or changes to the protocol. Furthermore, the Catania1 Ethics Committee of the Catania Polyclinic found the consent of the study participants unnecessary as the study concerned only the retrospective review of the medical database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}